• 15May2026
    [[TitleNews]]
    Carboplatin API (CAS 41575-94-4): 2026 Efficacy, Dosing, and B2B Sourcing Guide

    Secure pharmaceutical-grade Carboplatin API (CAS 41575-94-4). Shaanxi Sunrise guarantees ≥99.5% purity, GMP compliance, and strict impurity profiling.

    read more
  • 14May2026
    [[TitleNews]]
    How Is Pembrolizumab Reshaping 2026 Oncology R&D Procurement?

    Discover 2026 sourcing trends for Pembrolizumab API (CAS 1374853-91-4). Shaanxi Sunrise offers high-purity materials for biosimilar & SC formulation R&D.


    read more
  • 14May2026
    [[TitleNews]]
    Paclitaxel (CAS 33069-62-4) in 2026: Efficacy and Sourcing

    Discover the 2026 market outlook for Paclitaxel (CAS 33069-62-4). Shaanxi Sunrise provides high-purity API sourcing, nanocarrier delivery insights, and clinical efficacy trends for global B2B procurement

    read more